BNTX Competitors & Alternatives
Compare BioNTech SE with similar stocks in the same industry
Biotechnology
BNTX
Main Stock$87.65
Tradestie Score
62
Market Cap
$24.57B
Revenue Growth
-0.2%
Analyst Upside
+29.5%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$120.75
|
$31.13B | - | 37 | Compare |
|
GMAB
Genmab A/S ADS
|
$53.87
|
$19.56B | 46.2 | 33 | Compare |
|
INCY
Incyte Genomics Inc
|
$122.27
|
$16.93B | 61.4 | 52 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$70.01
|
$15.70B | 45.4 | 36 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.64
|
$15.22B | - | 42 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$259.28
|
$12.36B | 19.7 | 34 | Compare |
|
EXEL
Exelixis Inc
|
$70.70
|
$11.09B | 21.1 | 23 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$41.85
|
$10.76B | - | 42 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$248.69
|
$10.74B | - | 34 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$58.33
|
$10.53B | - | 56 | Compare |
More BNTX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2836)
218 stocks in this industry